EBIT Margin: Earnings before interest and taxes as a portion of total revenues. Calculated as: EBIT / Total Revenues
Capstone Therapeutics Corp. (CAPS) EBIT Margin data is not available for the most recently reported fiscal quarter, ending 2019-06-30.
| Income Statement Financials | |
-- |
|
$-0.67M |
|
-- |
|
-- |
|
$0.60M |
|
$-0.60M |
|
$-0.06M |
|
$-0.67M |
|
$-0.67M |
|
$-0.67M |
|
$-0.67M |
|
$-0.67M |
|
$-0.67M |
|
$-0.60M |
|
$-0.60M |
|
0.05M |
|
0.05M |
|
$-10.00 |
|
$-10.00 |
|
| Balance Sheet Financials | |
$0.70M |
|
-- |
|
-- |
|
$0.70M |
|
$0.82M |
|
$2.64M |
|
$2.64M |
|
$3.46M |
|
$-2.76M |
|
$-2.76M |
|
$-2.76M |
|
0.05M |
|
| Cash Flow Statement Financials | |
$-1.09M |
|
-- |
|
$0.05M |
|
$1.34M |
|
$0.30M |
|
$-1.04M |
|
$0.01M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.86 |
|
-- |
|
-- |
|
-22.79 |
|
-0.96 |
|
-- |
|
-- |
|
|
EBIT Margin |
-- |
-- |
|
-- |
|
-- |
|
$-1.09M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
24.20% |
|
24.20% |
|
-95.02% |
|
575.86% |
|
$-50.75 |
|
$-19.97 |
|
$-19.97 |
|